glp 1 injections Understanding GLP-1 pills: A new weight loss alternative to Understanding GLP-1 medications

This may be especially important, because some data suggest that these screening instruments may improve the ability of physicians to predict long-term clinical outcomes, including hospitalization for alcohol-related diagnoses

Skip the guesswork and the unregulated vials

Am J Dermatopathol 2015

GLP-1 RAs did not improve the change in LVEF (mean difference [MD]): 0.86, p = 0.12, left-ventricular end-diastolic volume (LVEDV) (MD: 3.54, p = 0.11), left-ventricular end-systolic volume (LVESV) (MD: 2.78, p = 0.07) or N-terminal pro-B-type natriuretic peptide (NT-proBNP) (MD: 140.36, p = 0.08)

both are research-planning choices